Dexilant (dexlansoprazole) NDC 64764-171

NDC codes

FDA NDC Directory

Product NDC (as listed)64764-171Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64764-0171Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
64764-171-00	64764017100	7 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-00)Marketed from Apr 12, 2010
64764-171-01	64764017101	5 BLISTER PACK in 1 TRAY (64764-171-01) / 4 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKMarketed from Apr 12, 2010
64764-171-03	64764017103	1 BOTTLE in 1 CARTON (64764-171-03) / 5 CAPSULE, DELAYED RELEASE in 1 BOTTLEMarketed from Apr 12, 2010
64764-171-11	64764017111	10 BLISTER PACK in 1 CARTON (64764-171-11) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACKMarketed from Apr 12, 2010
64764-171-19	64764017119	1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-19)Marketed from Apr 12, 2010
64764-171-30	64764017130	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-30)Marketed from Apr 12, 2010
64764-171-90	64764017190	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90)Marketed from Apr 12, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexilant
Generic name (nonproprietary): dexlansoprazole
Active ingredients: Dexlansoprazole — 30 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Takeda Pharmaceuticals America, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022287
Marketing start: Apr 12, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 64764-171_402fdd3a-6183-4a0d-85ac-61d4221fc921SPL ID 402fdd3a-6183-4a0d-85ac-61d4221fc921SPL set ID 9819f033-3bbe-442e-8e92-45fec77b237dRxCUI 833204, 833213, 902624, 902626UNII UYE4T5I70XUPC 0364764175306, 0364764171308
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464764017100 followed by a unit qualifier and the quantity

Package 64764-0171-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2025.

Indications (excerpt from the label)

DEXILANT is a proton pump inhibitor (PPI) indicated in patients 12 years of age and older for: Healing of all grades of erosive esophagitis (EE). ( 1.1 ) Maintenance of healed EE and relief of heartburn. ( 1.2 ) Treatment of symptomatic non-erosive gastroesophageal reflux disease (GERD). ( 1.3 ) 1.1 Healing of Erosive Esophagitis DEXILANT ® is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks. 1.2 Maintenance of Healed Erosive Esophagitis and Relief of Heartburn DEXILANT is indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in pa…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022287

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022287
Product	Strength	Form · route	Labeler	Product NDC
Dexlansoprazole delayed releasedexlansoprazole	Dexlansoprazole 60 mg/1	Capsule, Delayed releaseOral	A-S Medication Solutions	50090-5944
Dexilantdexlansoprazole	Dexlansoprazole 60 mg/1	Capsule, Delayed releaseOral	Takeda Pharmaceuticals America, Inc.	64764-175